Skip to content
2000
Volume 25, Issue 33
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Cancer is a widespread disease characterized by high mortality. To improve the survival rate or facilitate effective therapy, accurate and reliable diagnosis at an early stage is needed. For this reason, there is a continuous push to develop sensitive methods which can be used in cancer diagnosis. Current diagnosis relies on the quantification of cancer biomarkers defined as molecules that are measurable in body fluids or tissues and indicate a change in physiological processes with subsequent pathological manifestations. This contribution reviews recent developments in the area of electrochemical immunosensors applicable for the detection of cancer biomarkers that occur in a wide concentration range including extremely low levels, which are typical for the early stage of the disease. A summary of various antibody labels used for biomarker analysis and combined with electrochemical detection is presented. The potential of multiple biomarker analysis, with its indisputable clinical impact for accurate diagnosis, is also highlighted.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867324666171121101245
2018-10-01
2025-05-31
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867324666171121101245
Loading

  • Article Type:
    Review Article
Keyword(s): biomarker; Cancer; diagnosis; electrochemical detection; immunosensors; multiplex assay
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test